NIH-funded research R01 grant

Immune cell protection after cardiac arrest

Official title: Protective adaptive immune mechanisms after cardiac arrest

Funded at Mainehealth · NIH-11251567 · Data updated 2026-11-12

This project looks at whether immune cells that produce adenosine can calm inflammation and help people recover after cardiac arrest.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMainehealth
NIH-funded
Lab location1 site (Portland, United States)
Project startApril 2, 2024
Project endJanuary 31, 2029
Funding year2026
Award (this year)$638,127
NIH project number5R01HL173118-03
Project IDNIH-11251567 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for future translation would be people who have survived cardiac arrest and are recovering from heart or brain injury.

Less likely to help

People who did not have a cardiac arrest or whose problems are caused by non-inflammatory conditions are unlikely to benefit from this approach.

What this research studies

After a cardiac arrest, many people develop widespread inflammation that can harm the heart and brain. The team found in patients that higher numbers of CD73-expressing lymphocytes were linked with better outcomes and is using mouse models to study how those cells work. They will test giving protective CD73 immune cells after resuscitation in mice, examine how these lymphocytes form complexes with monocytes to create anti-inflammatory macrophages, and define the molecular steps involved. The aim is to learn whether boosting these cells could be developed into treatments for people who survive cardiac arrest.

Why it matters

Potential benefit: If successful, this work could point to new therapies that reduce damaging inflammation and improve heart and brain recovery after cardiac arrest.

How similar studies have gone: Past studies link CD73 and adenosine to reduced inflammation, but using CD73-expressing immune cells as a therapy after cardiac arrest is a novel and early approach.

Where this research is happening

  • Mainehealth
    Portland, United States
    Active

Researchers

  • Principal investigator: Ryzhov, Sergey — Mainehealth
  • Study coordinator: Ryzhov, Sergey

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.